Recombinant Soluble CD32 Suppresses Disease Progression in Experimental Epidermolysis Bullosa Acquisita  Hiroaki Iwata, Elena Pipi, Nicole Möckel, Peter.

Slides:



Advertisements
Similar presentations
Involvement of Wnt Signaling in Dermal Fibroblasts
Advertisements

Autoantibodies to Multiple Epitopes on the Non-Collagenous-1 Domain of Type VII Collagen Induce Blisters  Artem Vorobyev, Hideyuki Ujiie, Andreas Recke,
1α,25-Dihydroxycholecalciferol and Cyclosporine Suppress Induction and Promote Resolution of Psoriasis in Human Skin Grafts Transplanted on to SCID Mice 
Autoantibodies in Scurfy Mice and IPEX Patients Recognize Keratin 14
Effect of Superoxide Dismutase on Bleomycin-Induced Dermal Sclerosis: Implications for the Treatment of Systemic Sclerosis  Toshiyuki Yamamoto, Shinsuke.
IgG from Patients with Bullous Pemphigoid Depletes Cultured Keratinocytes of the 180- kDa Bullous Pemphigoid Antigen (Type XVII Collagen) and Weakens Cell.
The Leukotriene B4 and its Receptor BLT1 Act as Critical Drivers of Neutrophil Recruitment in Murine Bullous Pemphigoid-Like Epidermolysis Bullosa Acquisita 
Local Arginase 1 Activity Is Required for Cutaneous Wound Healing
Blocking Von Willebrand Factor for Treatment of Cutaneous Inflammation
Α-1-Antitrypsin and IFN-γ Reduce the Severity of IC-Mediated Vasculitis by Regulation of Leukocyte Recruitment In Vivo  Micha Feld, Tobias Goerge, Carina.
Hiroshi Koga, Andreas Recke, Gestur Vidarsson, Hendri H. Pas, Marcel F
The Leukotriene B4 and its Receptor BLT1 Act as Critical Drivers of Neutrophil Recruitment in Murine Bullous Pemphigoid-Like Epidermolysis Bullosa Acquisita 
Type I IL-1 Receptor Mediates IL-1 and Intracellular IL-1 Receptor Antagonist Effects in Skin Inflammation  Gaby Palmer, Dominique Talabot-Ayer, Gürkan.
The Autoantigen in Anti-p200 Pemphigoid Is Synthesized by Keratinocytes and Fibroblasts and Is Distinct from Nidogen-2  Silke C. Hofmann, Ursula Voith,
Epidermolysis Bullosa Acquisita Develops in Dominant Dystrophic Epidermolysis Bullosa  Ryota Hayashi, Ken Natsuga, Mika Watanabe, Hiroaki Iwata, Satoru.
Galectin-1 Accelerates Wound Healing by Regulating the Neuropilin-1/Smad3/NOX4 Pathway and ROS Production in Myofibroblasts  Yueh-Te Lin, Jhih-Sian Chen,
Oral Administration of Poly-γ-Glutamate Ameliorates Atopic Dermatitis in Nc/Nga Mice by Suppressing Th2-Biased Immune Response and Production of IL-17A 
Site of Blood Vessel Damage and Relevance of CD18 in a Murine Model of Immune Complex-Mediated Vasculitis  Anca Sindrilaru, Stephan Seeliger, Jan M. Ehrchen,
Blocking Potassium Channels (Kv1
Soluble Peptide Treatment Reverses CD8 T-Cell-Induced Disease in a Mouse Model of Spontaneous Tissue-Selective Autoimmunity  So Yeon Paek, Fumi Miyagawa,
Role of Monocyte Chemoattractant Protein-1 and its Receptor,CCR-2, in the Pathogenesis of Bleomycin-Induced Scleroderma  Toshiyuki Yamamoto, Kiyoshi Nishioka 
Dimethylfumarate Impairs Neutrophil Functions
Effects of Intravenous Immunoglobulins on Mice with Experimental Epidermolysis Bullosa Acquisita  Misa Hirose, Benjamin Tiburzy, Norito Ishii, Elena Pipi,
C-Terminal Processing of Collagen XVII Induces Neoepitopes for Linear IgA Dermatosis Autoantibodies  Ellen Toyonaga, Wataru Nishie, Kentaro Izumi, Ken.
Aspartame Attenuates 2, 4-Dinitrofluorobenzene-Induced Atopic Dermatitis–Like Clinical Symptoms in NC/Nga Mice  Gun-Dong Kim, Yong Seek Park, Hyun-Jong.
Comparative Effectiveness Research
Histamine Contributes to Tissue Remodeling via Periostin Expression
Methylprednisolone Blocks Autoantibody-Induced Tissue Damage in Experimental Models of Bullous Pemphigoid and Epidermolysis Bullosa Acquisita through.
Caspase-14-Deficient Mice Are More Prone to the Development of Parakeratosis  Esther Hoste, Geertrui Denecker, Barbara Gilbert, Filip Van Nieuwerburgh,
Topically Applied Flightless I Neutralizing Antibodies Improve Healing of Blistered Skin in a Murine Model of Epidermolysis Bullosa Acquisita  Zlatko.
Michael Kasperkiewicz, Christian D. Sadik, Katja Bieber, Saleh M
Topically Applied Hsp90 Blocker 17AAG Inhibits Autoantibody-Mediated Blister-Inducing Cutaneous Inflammation  Stefan Tukaj, Katja Bieber, Konrad Kleszczyński,
The Anti-C1s Antibody TNT003 Prevents Complement Activation in the Skin Induced by Bullous Pemphigoid Autoantibodies  Anika Kasprick, Maike M. Holtsche,
Induction of Epidermolysis Bullosa Acquisita in Mice by Passive Transfer of Autoantibodies from Patients  David T. Woodley, Ramin Ram, Arvin Doostan,
Epidermal COX-2 Induction Following Ultraviolet Irradiation: Suggested Mechanism for the Role of COX-2 Inhibition in Photoprotection  Catherine S. Tripp,
Toshiyuki Yamamoto, Kiyoshi Nishioka 
Ralf J. Ludwig, Susen Müller, Andreia d C
Evidence that Anti-Type VII Collagen Antibodies Are Pathogenic and Responsible for the Clinical, Histological, and Immunological Features of Epidermolysis.
Prolonged Activation of ERK Contributes to the Photorejuvenation Effect in Photodynamic Therapy in Human Dermal Fibroblasts  Yong Hyun Jang, Gi-Bang Koo,
Junctional Adhesion Molecules (JAM)-B and -C Contribute to Leukocyte Extravasation to the Skin and Mediate Cutaneous Inflammation  Ralf J. Ludwig, Thomas.
SIRT1 Activation Ameliorates Aldara-Induced Psoriasiform Phenotype and Histology in Mice  Sijing Xie, Zhonglan Su, Bin Zhang, Jiuyu Ge, Shiyu Song, Guibo.
Sustained Activation of Fibroblast Transforming Growth Factor-β/Smad Signaling in a Murine Model of Scleroderma  Shinsuke Takagawa, Gabriella Lakos, Yasuji.
Elevated Dietary Magnesium Prevents Connective Tissue Mineralization in a Mouse Model of Pseudoxanthoma Elasticum (Abcc6−/−)  Jennifer LaRusso, Qiaoli.
Extracellular Adherence Protein of Staphylococcus aureus Suppresses Disease by Inhibiting T-Cell Recruitment in a Mouse Model of Psoriasis  Honglin Wang,
Epitope-Dependent Pathogenicity of Antibodies Targeting a Major Bullous Pemphigoid Autoantigen Collagen XVII/BP180  Mayumi Wada, Wataru Nishie, Hideyuki.
In Vitro Keratinocyte Dissociation Assay for Evaluation of the Pathogenicity of Anti- Desmoglein 3 IgG Autoantibodies in Pemphigus Vulgaris  Ken Ishii,
Ekatherina Vassina, Martin Leverkus, Shida Yousefi, Lasse R
Autoantibodies to Bullous Pemphigoid Antigen 180 Induce Dermal–Epidermal Separation in Cryosections of Human Skin  Cassian Sitaru, Enno Schmidt, Steffen.
Increased Severity of Bleomycin-Induced Skin Fibrosis in Mice with Leukocyte-Specific Protein 1 Deficiency  JianFei Wang, Haiyan Jiao, Tara L. Stewart,
Peroxynitrite Production, DNA Breakage, and Poly(ADP-ribose) Polymerase Activation in a Mouse Model of Oxazolone-Induced Contact Hypersensitivity  Éva.
Botulinum Neurotoxin A Decreases Infiltrating Cutaneous Lymphocytes and Improves Acanthosis in the KC-Tie2 Mouse Model  Nicole L. Ward, Kevin D. Kavlick,
Identification of a Potential Effector Function for IgE Autoantibodies in the Organ- Specific Autoimmune Disease Bullous Pemphigoid  Otobia G. Dimson,
Journal of Investigative Dermatology
Loxosceles Sphingomyelinase Induces Complement-Dependent Dermonecrosis, Neutrophil Infiltration, and Endogenous Gelatinase Expression  Denise V. Tambourgi,
Valrubicin in a Topical Formulation Treats Psoriasis in a Xenograft Transplantation Model  Cecilia Rosada, Karin Stenderup, Elisabeth de Darkó, Frederik.
Epidermal CCL27 Expression Is Regulated during Skin Development and Keratinocyte Differentiation  Michael Mildner, Marion Prior, Maria Gschwandtner, Christopher.
Masaki Nagai, Minoru Hasegawa, Kazuhiko Takehara, Shinichi Sato 
Oral Administration of Poly-γ-Glutamate Ameliorates Atopic Dermatitis in Nc/Nga Mice by Suppressing Th2-Biased Immune Response and Production of IL-17A 
Novel Anti-Inflammatory Properties of the Angiogenesis Inhibitor Vasostatin  Rainer Huegel, Paula Velasco, Maria De La Luz Sierra, Enno Christophers, Jens.
Dagmar Simon, Luca Borradori, Hans-Uwe Simon 
Tannic Acid and Quercetin Display a Therapeutic Effect in Atopic Dermatitis via Suppression of Angiogenesis and TARC Expression in Nc/Nga Mice  Min Kyung.
FcγRIIA and FcγRIIIB Are Required for Autoantibody-Induced Tissue Damage in Experimental Human Models of Bullous Pemphigoid  Xinhua Yu, Karoline Holdorf,
IL-17A Upregulates Keratin 17 Expression in Keratinocytes through STAT1- and STAT3- Dependent Mechanisms  Xiaowei Shi, Liang Jin, Erle Dang, Ting Chang,
The Thomsen-Friedenreich Antigen-Binding Lectin Jacalin Interacts with Desmoglein-1 and Abrogates the Pathogenicity of Pemphigus Foliaceus Autoantibodies.
Autoantibodies to BP180 Associated with Bullous Pemphigoid Release Interleukin-6 and Interleukin-8 from Cultured Human Keratinocytes  Enno Schmidt, Stanislaus.
Foxp3+ Regulatory T Cells of Psoriasis Patients Easily Differentiate into IL-17A- Producing Cells and Are Found in Lesional Skin  H. Jorn Bovenschen, Peter.
Systemic PPARγ Ligation Inhibits Allergic Immune Response in the Skin
All-Trans Retinoic Acid Antagonizes UV-Induced VEGF Production and Angiogenesis via the Inhibition of ERK Activation in Human Skin Keratinocytes  Mi-Sun.
Errata Journal of Investigative Dermatology
Generation of Antibodies of Distinct Subclasses and Specificity Is Linked to H2s in an Active Mouse Model of Epidermolysis Bullosa Acquisita  Ralf J.
Presentation transcript:

Recombinant Soluble CD32 Suppresses Disease Progression in Experimental Epidermolysis Bullosa Acquisita  Hiroaki Iwata, Elena Pipi, Nicole Möckel, Peter Sondermann, Artem Vorobyev, Nina van Beek, Detlef Zillikens, Ralf J. Ludwig  Journal of Investigative Dermatology  Volume 135, Issue 3, Pages 916-919 (March 2015) DOI: 10.1038/jid.2014.451 Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 sCD32 inhibits neutrophil activation ex vivo by immune complexes (IC). (a) IC were generated by incubation of human IgG on 96-well plates. After washing, human neutrophils were added in the presence or absence of sCD32. Neutrophil activation was assayed by measuring reactive oxygen species (ROS) production. sCD32 inhibited ROS production from IC-activated neutrophils in a dose-dependent manner. Data are based on five experiments, using different leukocyte donors, per group (*P<0.05, analysis of variance (ANOVA)), and expressed as mean±SEM. (b) Cryosections from normal human skin were incubated with sera from bullous pemphigoid (BP) patients. Subsequently, leukocytes from healthy blood donors were added. This induced dermal–epidermal separation in the absence of sCD32. In the presence of sCD32, autoantibody-induced, leukocyte-dependent dermal–epidermal separation was significantly impaired. Data are based on 21 experiments, that is, different BP sera and leukocyte donors, per group (*P<0.05 vs. positive control, ANOVA), and expressed as mean±SEM. (c) Similar results were obtained when incubating normal human skin with epidermolysis bullosa acquisita (EBA) patient IgG (n=1) and leukocytes from healthy blood donors (n=5). In all sections incubated with EBA patient IgG, dermal–epidermal separation was induced; in contrast to the experiments using BP sera, a wider variation was observed (ranging from 2% to 100%). Therefore, data were normalized to the dermal–epidermal separation of the positive control (set at 100%). Simialar to experiments using BP patient serum, sCD32 also impaired dermal–epidermal separation induced by EBA serum. Compared with positive EBA control serum, dermal–epidermal separation was reduced to 61±6% in sCD32-treated sections (concentration: 0.5 mg ml-1; P<0.001, t-test). A representative example of each treatment group from a total of five experiments is demonstrated. Asterisks indicate the position of dermal–epidermal junction without any separation, and arrows indicate areas of dermal–epidermal separation. Bar=200 μm. Journal of Investigative Dermatology 2015 135, 916-919DOI: (10.1038/jid.2014.451) Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 2 sCD32 suppresses progression of already established experimental epidermolysis bullosa acquisita (EBA). (a) Arrow at week 0 indicates starting point of treatment (left). Compared with phosphate-buffered saline (PBS)-injected mice, sCD32 treatment led to significantly fewer skin lesions. Data are based on total 13 mice per group (left, *P<0.05, t-test), and expressed as mean±SEM. Overall, clinical disease severity (area under the curve (AUC)) was lower in mice treated with sCD32 (right, P=0.031, t-test). (b) Representative clinical pictures 4 weeks after allocation to PBS (left) or sCD32 treatment (right). (c) The score of dermal infiltrates was significantly lower in mice treated with sCD32 (P<0.05, t-test). Representative hematoxylin and eosin (H&E)-stained sections of skin from mice treated with sCD32 (right) or PBS (left) are shown. Numbers in upper right corners indicate the mean±SEM of the semiquantitative scored infiltration, ranging from 0 (no infiltration) to 3 (severe dermal infiltration). Bar=200 μm. (d) Mice treated with sCD32 had ∼20% less autoantibodies compared with control (P=0.048; t-test). (e) The fluorescence intensity of IgG was not different. Representative pictures of IgG deposits. Bar=50 μm. Journal of Investigative Dermatology 2015 135, 916-919DOI: (10.1038/jid.2014.451) Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions